(Q48030704)

7 February 2018

title

Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization (English)

1 reference

7 February 2018

0 references

3

Gilbert S

1 reference

7 February 2018

author name string

Allsopp CE

1

1 reference

7 February 2018

Plebanski M

2

1 reference

7 February 2018

Sinden RE

4

1 reference

7 February 2018

Harris S

5

1 reference

7 February 2018

Frankel G

6

1 reference

7 February 2018

Dougan G

7

1 reference

7 February 2018

Hioe C

8

1 reference

7 February 2018

Nixon D

9

1 reference

7 February 2018

Paoletti E

10

1 reference

7 February 2018

Layton G

11

1 reference

7 February 2018

Hill AV

12

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 August 1996

1 reference

7 February 2018

European Journal of Immunology

published in

1 reference

7 February 2018

volume

26

1 reference

7 February 2018

issue

8

1 reference

7 February 2018

page(s)

1951-1959

1 reference

7 February 2018

The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

Circumsporozoite protein of Plasmodium berghei: gene cloning and identification of the immunodominant epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Mutations with multiple independent origins in surface antigens mark the targets of biological selective pressure

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Common west African HLA antigens are associated with protection from severe malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Molecular analysis of the association of HLA-B53 and resistance to severe malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

An HLA-based approach to the design of a CTL-inducing vaccine against Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Galactose oxidation in the design of immunogenic vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Studies using a recombinant vaccinia virus expressing the circumsporozoite protein of Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Nucleotide sequence of the Plasmodium berghei circumsporozoite protein gene from the ANKA clone 2.34L.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Induction of peptide-specific primary cytotoxic T lymphocyte responses from human peripheral blood

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Cytotoxic T-cell immunity to influenza.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Vaccinia from recombinant virus expressing HIV genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

The expression of hybrid HIV:Ty virus-like particles in yeast

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

The cleavage preference of the proteasome governs the yield of antigenic peptides.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260841

7 January 2021

Identifiers

DOI

10.1002/EJI.1830260841

1 reference

7 February 2018

1 reference

7 February 2018